Full-Service, Fully Committed
CordenPharma, the global pharmaceutical service & manufacturing platform of International Chemical Investors Group (ICIG), is a full-service Contract Development & Manufacturing Organization (CDMO) for the production of APIs, Drug Products, and associated Packaging Services. Through a growing network of focused investments across Europe and the US organized under Technology Platforms, CordenPharma experts translate complex processes, ideas and projects at any stage of development into high-value products.
CordenPharma’s vertically-integrated supply chain model provides development & manufacturing expertise spanning the complete cGMP supply chain > from regulated raw materials through intermediates, APIs, commercial-scale Drug Product manufacturing, finished dosage formulation, packaging, clinical trial services, & pharma logistics > resulting in reduced development & manufacturing time and cost.
News & Press
- January 24, 2022
COVID-19 > Read CEO Dr. Micheal Quirmbach's Customer Letter Response to COVID-19.
- January 18, 2022
Press Release > CordenPharma Collaborates with PeptiSystems on Green Continuous Peptide Manufacturing.
- January 13, 2021
DCAT Value Chain Insights Interview: CEO Michael Quirmbach Talks Trends & Issues in the CDMO Sector for 2022.
CORDENPHARMA 15 YEAR ANNIVERSARY VIDEOS
DCAT Week '22
March 21 - 24, 2022
Lotte New York Palace Suites 5008 & 4911
May 9 - 12, 2022
Boston Convention Center
Boston, MA USA
CPhI North America
May 17 - 19, 2022
Pennsylvania Convention Center
Philadelphia, PA USA
Browse our library of Brochures, Product Lists, White Papers, Videos & Webinars.
Place an inquiry here > one of our team of experts will get back to you.